We are live on ! Find out more
RC

Rangeley Capital Portfolio holdings

AUM $109M
1-Year Est. Return 97.13%
This Fund
S&P 500
This Quarter Est. Return
+34.11%
1 Year Est. Return
+97.13%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$109M
AUM Growth
+$6.53M
Cap. Flow
-$6.26M
Cap. Flow %
-5.72%
Top 10 Hldgs %
32.08%
Holding
212
New
75
Increased
28
Reduced
43
Closed
29

Sector Composition

Rank Sector Weight
1 Healthcare 27.11%
2 Consumer Discretionary 14.33%
3 Financials 12.51%
4 Miscellaneous 10.11%
5 Real Estate 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BOLD
126
Boundless Bio
BOLD
$64.4M
$185K 0.17%
+74,000
New +$114K
EMIS
127
Emmis Acquisition Corp
EMIS
$183K 0.17%
18,107
APXT
128
Apex Treasury Corp
APXT
$466M
$178K 0.16%
+17,701
New +$177K
ALIT icon
129
Alight
ALIT
$325M
$176K 0.16%
15,745
+13,272
+537% +$188K
BCARU
130
DELISTED
D. Boral ARC Acquisition I Corp Units
BCARU
$173K 0.16%
15,239
-57,191
-79% -$661K
NKTX icon
131
Nkarta
NKTX
$209M
$170K 0.16%
60,000
-8,000
-12% -$22.5K
TACOW
132
Berto Acquisition Corp Warrant
TACOW
$16.2M
$168K 0.15%
16,000
+500
+3% +$270
KYIV
133
Kyivstar Group
KYIV
$3.17B
$162K 0.15%
10,000
FACT
134
FACT II Acquisition Corp
FACT
$261M
$158K 0.14%
14,886
-624
-4% -$6.62K
DBRG icon
135
DigitalBridge
DBRG
$2.98B
$158K 0.14%
10,000
BBCQ
136
DELISTED
Bleichroeder Acquisition Corp II
BBCQ
$155K 0.14%
+15,000
New +$155K
RPD icon
137
CALL
Rapid7
RPD
$690M
$151K 0.14%
+18,700
New +$124K
IMXI icon
138
International Money Express
IMXI
$428M
$145K 0.13%
10,000
HCMA
139
HCM III Acquisition Corp
HCMA
$348M
$144K 0.13%
14,046
+1,516
+12% +$15.5K
PMVP icon
140
PMV Pharmaceuticals
PMVP
$79.1M
$133K 0.12%
99,240
+32,394
+48% +$41.6K
ALLO icon
141
Allogene Therapeutics
ALLO
$612M
$128K 0.12%
+61,500
New +$135K
PEPG icon
142
PepGen
PEPG
$205M
$126K 0.12%
70,000
+1,904
+3% +$3.1K
TWO
143
DELISTED
Two Harbors Investment
TWO
$124K 0.11%
10,000
BRNS
144
DELISTED
Barinthus Biotherapeutics
BRNS
$122K 0.11%
185,136
+25,671
+16% +$16.7K
TACO
145
Berto Acquisition Corp
TACO
$393M
$121K 0.11%
+11,538
New +$120K
IMA
146
ImageneBio Inc
IMA
$58.3M
$119K 0.11%
20,090
-12,500
-38% -$70.6K
FMC icon
147
FMC
FMC
$1.43B
$115K 0.11%
10,000
RAAQ
148
DELISTED
Real Asset Acquisition Corp
RAAQ
$108K 0.1%
10,000
MREO
149
Mereo BioPharma
MREO
$43.4M
$105K 0.1%
329,200
SZZL
150
Sizzle Acquisition Corp II
SZZL
$104K 0.09%
10,000

Similar funds

Rangeley Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Rangeley Capital held 212 positions worth $109M, up 6.3% from $103M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Rangeley Capital withdrew a net $6.26M in Q2 2026, closing 29 positions and reducing 43 holdings. Its most notable exit was Leggett & Platt, an estimated $2.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Rangeley Capital opened a new position in Nomad Foods worth $1.48M.

  • Rangeley Capital's largest Q2 2026 buy was Nomad Foods: 135,000 shares worth $1.48M.
  • Rangeley Capital added most to Distribution Solutions Group in Q2 2026, an estimated $1.26M increase.
  • Rangeley Capital's biggest Q2 2026 reduction was Revolution Medicines, cutting an estimated $8.47M.
  • Rangeley Capital fully exited Leggett & Platt in Q2 2026, selling an estimated $2.1M.
  • Rangeley Capital's ten largest holdings make up 32% of its $109M portfolio in Q2 2026.
  • Rangeley Capital opened 75 new positions and closed 29 in Q2 2026.
  • Rangeley Capital's portfolio value rose 6.3% quarter-over-quarter to $109M.

Based on Rangeley Capital's 13F filing for Q2 2026, filed 14 Aug 2026.